Study: Antidepressant Paxil might prevent heart failure

Share this article:

The antidepressant Paxil has shown promise in strengthening the heart, new research suggests.

In a discovery that University of Michigan researcher John Tesmer, Ph.D., described as “completely serendipitous,” the drug paroxetine, a.k.a. Paxil, inhibits G protein-coupled receptor kinase 2. That's a protein that becomes over-expressed when people have heart failure.

According to Tesmer, paroxetine improved the strength of the heart's contractions in an animal model, without interfering with the heart rate. Although the drug is not currently prescribed in doses large enough to have a therapeutic effect, further development of the drug's key compounds could yield leads within the next several years, researchers said.

The only caveat: SSRIs, often used to treat depression in nursing home residents, have been associated with an increased risk of falls in the elderly.

The study was published online in ACS Chemical Biology.

Share this article:

More in News

Septicemia, urinary tract infections rank high on latest list of hospital readmissions causes

Septicemia, urinary tract infections rank high on latest ...

Two infectious conditions common in long-term care settings — septicemia and urinary tract infections — were among the top causes of hospital readmissions for Medicare beneficiaries in 2011, according to ...

PharMerica to pay $200,000 settlement over federal charges of unsafe dispensing practices

Long-term care pharmacy company PharMerica has agreed to pay about $213,000 to settle charges that it dispensed medications without prescriptions and committed other breaches of the Controlled Substances Act, federal authorities announced Wednesday.

Shortchanging the Older Americans Act has led to unnecessary nursing home placements, ...

Chronic underfunding of the Older Americans Act is leading to unnecessary long-term care facility admissions, Sen. Bernard Sanders (I-VT) and 26 of his Democratic colleagues in the Senate said in a recent letter to Appropriations Committee leaders.